Singapore

Broker's take

Compiled by Stephanie Luo,

The Business Times

SINGAPORE EXCHANGE LTD | NEUTRAL
APRIL 21 CLOSE: S$7.47
TARGET PRICE: S$7.45

Phillip Securities Research (Singapore), April 21

Excluding one-off loss of S$4 million from the disposal of shares of the Bombay Stock Exchange, Q3 FY06/17 Patmi (profit after tax and minority interests) would have decreased 2 per cent y-o-y (year-on-year) to S$87 million, in line with our expectations of S$83 million.

Operating expenses decreased because of lower processing and royalties expense and lower professional fees.

Total revenue was lower because of weaker y-o-y derivatives trading volume.

ASCOTT RESIDENCE TRUST | HOLD
APRIL 21 CLOSE: S$1.09
TARGET PRICE: S$1.105

OCBC Investment Research, April 21

Ascott Residence Trust's (ART) Q1 17 revenue increased 5.4 per cent yoy to S$111.3 million - mainly due to an additional revenue of S$5.8 million from the acquisition of Sheraton Tribeca New York last year - which was partially offset by the decline in revenue of S$1.8 million from existing properties (mainly Singapore and the UK).

Gross profit fell 2.9 per cent y-o-y to S$47.2 million despite the increase in revenue largely due to the recognition of operating lease expense on a straight-line basis in the United States.

JAPFA LTD | BUY
APRIL 21 CLOSE: S$0.63
TARGET PRICE: S$1

DBS Group Research, April 21

Japfa Ltd (JAP) is involved in all major animal proteins across different geographies in Asia's fast-growing regions. In our report, we adjusted FY17F/18F earnings to impute lower expected contribution from subsidiary Japfa Comfeed Indonesia (JPFA) due to weaker-than-expected Q1 17 day-old-chick (DOC) and live broiler prices.

We adjusted our forecasts to account for lower expected contribution from 51 per cent-owned JPFA (mainly from breeding and commercial farm segments - while feed contribution was raised slightly).

JAP's share price is driven by DOC, broiler and swine prices as well as China raw milk price movements and the USD/IDR exchange rate.

Disclaimer: All analyses, recommendations and other information herein are published for general information. Readers should not rely solely on the information published and should seek independent financial advice prior to making any investment decision. The publisher accepts no liability for any loss whatsoever arising from any use of the information published herein.